A first step to study the use and safety of multiple sclerosis (MS) drugs during pregnancy: Identifying cases of MS and assessing MS prevalence. A pilot study in a French health care datasource. A contribution from the ConcePTION project
Marie Beslay(Université Toulouse III - Paul Sabatier), Christine Damase‐Michel(Inserm), Clara Cavero‐Carbonell(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Sandra López‐León(Rutgers, The State University of New Jersey), Marco Manfrini(University of Padua), Vera Ruth Mitter(Bern University of Applied Sciences), Angela Lupattelli(University of Oslo), Yvonne Geissbühler(Novartis (Switzerland)), Anna‐Belle Beau(Inserm), Justine Bénevent(Université Toulouse III - Paul Sabatier), Davide Messina(Regional Health), Maarit K. Leinonen(University of Helsinki), Rosa Gini(Agenzia Regionale di Sanità della Toscana), Sue Jordan(Swansea University), Visa Martikainen(Finnish Institute for Health and Welfare), Amanda J. Neville(University of Ferrara), Hedvig Nordeng(University of Oslo), Anja Geldhof, Joan K. Morris(St George's, University of London)
HAL (Le Centre pour la Communication Scientifique Directe)
January 1, 2023
Cited by 0
Related Papers
Randomized Trial of Preventive Angioplasty in Myocardial Infarction
|New England Journal of Medicine|2013|1k
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
|The American Journal of Medicine|2009|941
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Cardiovascular morbidity and mortality after orthotopic liver transplantation
|Transplantation|2002|326
Child–Parent Familial Hypercholesterolemia Screening in Primary Care
|New England Journal of Medicine|2016|317